Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05938569 · ClinicalTrials.gov registry record · NA
Computer-Assisted Hair Restoration Study Using ARTAS System
A NA study of Androgenic Alopecia, sponsored by Venus Concept.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 2
- Study locations
NCT05938569 is a NA study of Androgenic Alopecia that is actively recruiting participants, run by Venus Concept. The registered enrollment target is 150 participants, above the 40-participant average among 4 other Androgenic Alopecia trials with a reported enrollment target (275% higher). The trial reports 2 study locations across 1 state.
The verdict
NCT05938569, a NA study of Androgenic Alopecia, is actively recruiting participants, sponsored by Venus Concept.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 2
- Study locations
Study Summary
Prospective, multi-center, up to 4 investigational centers evaluating the performance of the ARTAS System in Hair Restoration Procedures.
Conditions Studied
Interventions
- DEVICE Hair restoration
Study Locations (2)
California
- Berman Skin Institute - Los Altos
- Le's Aesthetics - San Jose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2016-11-03 |
| Est. Completion | 2026-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05938569
The ClinicalTrials.gov registry entry for NCT05938569 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 40-participant average among 4 other Androgenic Alopecia trials with a reported enrollment target (275% higher). The listed sponsor is Venus Concept, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Androgenic Alopecia appearing as the primary indexed condition, and to 1 intervention - of which Hair restoration is the first listed.
NCT05938569 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05938569 about?
NCT05938569 is a clinical study titled "Computer-Assisted Hair Restoration Study Using ARTAS System". Prospective, multi-center, up to 4 investigational centers evaluating the performance of the ARTAS System in Hair Restoration Procedures.
What is the current status of trial NCT05938569?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2016-11-03. Estimated completion is 2026-12-15.
What conditions does trial NCT05938569 study?
This clinical trial studies the following conditions: Androgenic Alopecia.
What interventions are being tested in trial NCT05938569?
The interventions under investigation include: Hair restoration (DEVICE).
Who is sponsoring clinical trial NCT05938569?
This trial is sponsored by Venus Concept, which has 22 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05938569 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Androgenic Alopecia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Autologous Hair Follicle Secretome for Androgenic Alopecia (Single Site)
RECRUITING · NA
-
Keravive by Hydrafacial for Scalp Health and Enhanced Hair Quality
COMPLETED · NA
-
A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss
COMPLETED · NA
-
Follicular Revival in Androgenic Alopecia: Evaluating Use of Micro-needling
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.